Prevalance of heparin-dependent platelet-activating antibodies in preterm newborns after exposure to unfractionated heparin

Clinical and Applied Thrombosis/Hemostasis

Volumn 10, Issue 4, 2004, Pages 335-339

  Kumar, Praveen ^a   Hoppensteadt, Debra A ^b   Prechel, M Margaret ^b   Deddish, Ruth B ^a   Walenga, Jeanine M ^b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Heparin induced thrombocytopenia; Heparin dependent platelet activating antibodies; Neonates; Very low birth weight infants

Indexed keywords

DRUG ANTIBODY; HEPARIN; HEPARIN DEPENDENT THROMBOCYTE ACTIVATING ANTIBODY; PROTEIN ANTIBODY; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4; THROMBOCYTE FACTOR 4 ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARINIZATION; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; PERINATAL DRUG EXPOSURE; PREMATURITY; PRIORITY JOURNAL; SEPSIS; THROMBOCYTOPENIA; THROMBOSIS; VERY LOW BIRTH WEIGHT;

AUTOANTIBODIES; BLOOD PLATELETS; CATHETERIZATION, CENTRAL VENOUS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PLATELET COUNT; PLATELET FACTOR 4; PREVALENCE; SEPSIS; THROMBOCYTOPENIA;

EID: 6344291521     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960401000405     Document Type: Article

References (29)

1. Lesko SM, Epstein MF, Mitchell AA. Recent patterns of drug use in newborn intensive care. J Pediatr 1990; 116:985.
2. Aster RH. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 1995;332:1374.
3. Spadone R, Clark F, James E, et al. Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 1992;15:306.
4. Collins JL, Aster RH, Moghaddam M, et al. Diagnostic testing for heparin-induced thrombocytopenia: An enhanced platelet factor 4 complex enzyme-linked immunosorbent assay [abstract]. Blood 1997;90:461a.
5. Amiral J, Bridey F, Wolf M, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases. Thromb Haemost 1995;73(1):21.
6. Amiral J, Wolf F, Fisher AM, et al. Pathogenicity of IgA and/or IgM antibodies to heparin PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 1996;92:954.
7. Walenga JM, Walter PJ, Fasanella AR, et al. Laboratory diagnosis of heparin-induced thrombocytopenia. Ciin Appl Thromb/Hemost 1999;5(1):S21.
8. Brieger DB, Mak KH, Kottke-Marchant K, et al. Heparin-induced thrombocytopenia. J Am Coll Cardiol 1998; 31:1449.
9. Chong BH. Heparin-induced thrombocytopenia. Br J Hematol 1995;89:431.
10. Greinacher A, Pötzsch B, Amiral J, et al. HIT: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994;71(2):247.
11. Kelton JG, Sheridan DP, Santos AV, et al. Heparin-induced thrombocytopenia: Laboratory studies. Blood 1988;72:925.
12. Walenga JM, Jeske WP, Prechel M, et al. New insights on the mechanism of heparin-induced thrombocytopenia. Semin Thromb Hemost, in press.
13. Jeske WP, Schlenker R, Bakhos M, et al. Are leukocytes important for platelet activation in heparin-induced thrombocytopenia? Ann Hematol 2000;79(Suppl 1):A46.
14. Pouplard C, Lochmann S, Renard B, et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 2001;97(10):3300.
15. Fareed J, Walenga JM, Hoppensteadt DA, et al. Selectins in the HIT syndrome. Pathophysiologic role and therapeutic modulation. Semin Thromb Hemost 1999;25(Suppl 1):37.
16. Visentin GP, Ford SE, Scott JP, et al. Antibodies from patients with heparin-induced thrombocytopenia are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93:81.
17. Wallis DE, Workman DL, Lewis BE, et al. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 1999;106(6):629.
18. Walls JT, Curtis JJ, Silver D, et al. Heparin-induced thrombocytopenia in patients who undergo open heart surgery. Surgery 1990;108(4):686.
19. Alving BM. How I treat heparin-induced thrombocytopenia and thrombosis. Blood 2003;101(1):31.
20. Walenga JM, Jeske WP, Fasanella AR, et al. Laboratory assays for the diagnosis of heparin-induced thrombocytopenia. Semin Thromb Hemost 1999;25(Suppl 1):43.
21. Bauer TL, Arepally G, Konkle BA, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997;95:1242.
22. Izban KF, Lietz HW, Hoppensteadt DA, et al. Comparison of two PF4/heparin elisa assays for the laboratory diagnosis of heparin-induced thrombocytopenia. Semin Thromb Hemost 1999;25(Suppl 1):51.
23. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993; 69(4):344.
24. Walenga JM, Jeske WP, Wood J, et al. Laboratory tests for heparin-induced thrombocytopenia: A multicenter study. Semin Hematol 1999;36(Suppl 1):22.
25. Pouplard C, Amiral J, Borg JY, et al. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1999;111:700.
26. Arepally G, Reynolds C, Tomaski A, et al. Comparison of PF4/heparin ELISA with the 14 C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1995;104:648.
27. Visentin GP, Malik M, Cyganiak KA, et al. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes. J Lab Clin Med 1996;128:376.
28. Williams RT, Damaraju LV, Mascelli MA, et al. Antiplatelet factor 4/heparin antibodies. An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes. Circulation 2003;107:2307.
29. Kadidal W, Mayo DJ, Horne MK. Heparin-induced thrombocytopenia (HIT) due to heparin flushes: A report of three cases. J Int Med 1999;246(3):325.